semaglutide menopause weight Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more if they were also using hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Compounded Semaglutide for Menopause |

Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients

The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Demand

The most common hormonal disorder in those assigned female at birth who are of reproductive age has a new name to better reflect a multisystem condition that can cause irregular periods, acne and increased risk of developing diabetes

The Science of Weight Regain and Why It Matters for Long-Term Planning One of the most clinically important findings to emerge from the GLP-1 and dual-agonist era is the magnitude of weight regain following discontinuation

Practical Implications for Weight Loss Understanding the science behind Retatrutides energy effects has practical implications for anyone considering or currently using this medication